Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
190.8 USD | -0.68% | -6.01% | -26.02% |
Apr. 17 | UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating | MT |
Apr. 17 | Wedbush Cuts Biogen's Price Target to $213 From $245 | MT |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.